Children's Cancer Group, China
Quick facts
Phase 3 pipeline
- Course A1 + Vin · Oncology
Course A1 + Vin is a combination chemotherapy regimen that uses vincristine (Vin) alongside other agents in Course A1 to disrupt microtubule formation and induce apoptosis in cancer cells. - Course A2 + Vin · Oncology
Course A2 + Vin is a combination chemotherapy regimen that uses doxorubicin and vincristine to inhibit cancer cell division and induce apoptosis in pediatric malignancies. - Course A3 + Vin · Oncology
Course A3 + Vin is a combination chemotherapy regimen combining doxorubicin, cyclophosphamide, and vincristine used to treat pediatric cancers. - Course B1 +Vin · Oncology
Course B1 + Vin is a chemotherapy combination regimen that uses vincristine (Vin) alongside other agents in Course B1 to disrupt microtubule formation and induce apoptosis in cancer cells. - Course B2 +Vin · Oncology
Course B2 + Vin is a chemotherapy combination regimen that uses vincristine (Vin) alongside other agents to inhibit microtubule formation and induce apoptosis in cancer cells. - Course B3 +Vin · Oncology
Course B3 + Vin is a combination chemotherapy regimen that uses vincristine (Vin) alongside other agents to disrupt cancer cell division and induce apoptosis in pediatric malignancies. - Dexamethasone, Cytarabine, Etoposide, Pegylated-asparaginase · Oncology
This combination regimen uses a corticosteroid, cytotoxic chemotherapy agents, and an amino acid-depleting enzyme to induce apoptosis and inhibit protein synthesis in leukemic cells. - Methotrexate, 6-mercaptopurine · Oncology
This combination of methotrexate and 6-mercaptopurine inhibits nucleotide synthesis and DNA replication to suppress cancer cell proliferation.
Phase 2 pipeline
- Bedamustine · Other
- Brentuximab Vedotin for Injection · Oncology
Brentuximab vedotin targets CD30, a protein found on the surface of certain cancer cells, and delivers a toxic agent to these cells. - Cyclophosphamide, Vincristine, Cytarabine, Doxorubincin, Prednisone
- Cyclophosphamide, Vindelsine, Cytarabine, Doxorubincin, Prednisone · Oncology
Cyclophosphamide is an alkylating agent that interferes with DNA replication, Vindelsine is a topoisomerase inhibitor that disrupts DNA replication, Cytarabine is a nucleoside analog that inhibits DNA synthesis, Doxorubicin is an anthracycline antibiotic that intercalates DNA, Prednisone is a corticosteroid that suppresses inflammation and immune response. - Ifosphamide, Etoposide, Methotrexate, Vincristine, Prednisone
- Ifosphamide, Etoposide, Methotrexate, Vindelsine, Prednisone · Oncology
Topoisomerase inhibitor - Prednisone,Vincristine, Cyclophosphamide
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Children's Cancer Group, China portfolio CI brief
- Children's Cancer Group, China pipeline updates RSS
Frequently asked questions about Children's Cancer Group, China
What is Children's Cancer Group, China's pipeline?
Children's Cancer Group, China has 8 drugs in Phase 3, 7 in Phase 2, 0 in Phase 1. Late-stage candidates include Course A1 + Vin, Course A2 + Vin, Course A3 + Vin, Course B1 +Vin.
Related
- Sector hub: All tracked pharma companies